Leucocytoclastic Vasculitis‐like Reaction Induced by Tocilizumab in a Patient with Rheumatoid Arthritis
HU Yong-fang,Xue Chen,Jianzhong Zhang
DOI: https://doi.org/10.1111/dth.15944
2022-01-01
Dermatologic Therapy
Abstract:Dermatologic TherapyVolume 35, Issue 12 e15944 LETTER Leucocytoclastic vasculitis-like reaction induced by tocilizumab in a patient with rheumatoid arthritis Yu-Qing Hu, Yu-Qing Hu orcid.org/0000-0002-6282-6436 Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJian-Zhong Zhang, Corresponding Author Jian-Zhong Zhang [email protected] orcid.org/0000-0002-5485-682X Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jian-Zhong Zhang, No. 11 South Avenue, Xi Zhi Men Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author Yu-Qing Hu, Yu-Qing Hu orcid.org/0000-0002-6282-6436 Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXue Chen, Xue Chen Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJian-Zhong Zhang, Corresponding Author Jian-Zhong Zhang [email protected] orcid.org/0000-0002-5485-682X Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jian-Zhong Zhang, No. 11 South Avenue, Xi Zhi Men Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author First published: 18 October 2022 https://doi.org/10.1111/dth.15944 Funding information: National Natural Science Foundation of China, Grant/Award Number: 82103711 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Choong DJ, Tan E. Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations. Dermatol Ther. 2021; 34(4):e14990. 2Schlapbach C, Navarini AA. The continuing evolution of targeted therapy for inflammatory skin disease. Semin Immunopathol. 2016; 38(1): 123-133. 3Palmou-Fontana N, Sanchez Gavino JA, McGonagle D, Garcia-Martinez E, Iniguez de Onzono Martin L. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis. Dermatology. 2014; 228(4): 311-313. 4Yoshiki R, Nakamura M, Tokura Y. Drug eruption induced by IL-6 receptor inhibitor tocilizumab. J Eur Acad Dermatol Venereol. 2010; 24(4): 495-496. 5Mori T, Yamamoto T. Tocilizumab-induced pustular drug eruption. Int J Rheum Dis. 2017; 20(11): 1776-1777. 6Sakaue S, Sumitomo S, Kubo K, Fujio K, Yamamoto K. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2014; 53(8): 1529-1530. 7Khan M, Madi MY, Rencic J. Apixaban-induced cutaneous leucocytoclastic vasculitis. BMJ Case Rep. 2020; 13(8):e237043. 8Giorgio V, Blasi E, Rigante D, et al. Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report. Int J Environ Res Public Health. 2021; 18(13):6711. 9Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008; 112(10): 3959-3964. Volume35, Issue12December 2022e15944 ReferencesRelatedInformation